Global framework for biosimilars "is now crucial"

Article Date: 25/04/2012 06:00
Global framework for biosimilars "is now crucial"

Vacancy Search

Quick job search

Advanced Search

Latest News

FDA approves new cystic fibrosis drug Orkambi

FDA approves new cystic fibrosis drug Orkambi

ViiV set to offer cheap HIV drugs in China

ViiV set to offer cheap HIV drugs in China

Sector’s smaller players show the way

With the Nasdaq biotech index proving remarkably resilient to sector-specific and macroeconomic problems alike, smart investors will continue to keep an eye out for signs of panic as a...

UK leads EU in antibiotic diagnostics research

UK leads EU in antibiotic diagnostics research

Pfizer teams up with NIHR

Pfizer teams up with NIHR

Boehringer COPD combination approved in Europe

Boehringer COPD combination approved in Europe

Opdivo launches in UK

Opdivo launches in UK

Medtech floats remain steady in 2015

The striking thing about the half-year figures for IPOs in the medtech sphere is the similarity they bear to those for the previous six-month period. The 14 device companies that have...

No letting up in pharma as first-half gains outweigh losses

Up and up and up it goes, and where it stops, nobody knows. Little has stood in the way of mounting valuations in pharma and biotech – notwithstanding the occasional wobble or...

US gov seeks $3.35bn from Novartis in kickbacks case

US gov seeks $3.35bn from Novartis in kickbacks case
more news